PAVmed Financial Statements From 2010 to 2024

PAVMZ Stock  USD 0.03  0.00  0.00%   
PAVmed Series financial statements provide useful quarterly and yearly information to potential PAVmed Series Z investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on PAVmed Series financial statements helps investors assess PAVmed Series' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting PAVmed Series' valuation are summarized below:
Revenue
3.8 M
Quarterly Revenue Growth
4.898
Revenue Per Share
0.459
We have found one hundred twenty available trending fundamental ratios for PAVmed Series Z, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of PAVmed Series Z recent market performance against the performance between 2010 and 2024 to make sure the company can sustain itself next year. Market Cap is likely to rise to about 57.7 M in 2024. Enterprise Value is likely to rise to about 62 M in 2024

PAVmed Series Total Revenue

1.52 Million

Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

PAVmed Series Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets23.6 M33.1 M16.1 M
Slightly volatile
Total Current Liabilities56.9 M54.2 M13.8 M
Slightly volatile
Cash18.9 M19.6 M13 M
Slightly volatile
Cash And Short Term Investments18.9 M19.6 M13 M
Slightly volatile
Common Stock Total Equity69.9273.69.9 K
Slightly volatile
Liabilities And Stockholders Equity23.6 M33.1 M16.1 M
Slightly volatile
Capital Surpluse105.7 M100.7 M38.6 M
Slightly volatile
Other Current AssetsM4.3 M21.9 B
Pretty Stable
Other Stockholder Equity249.5 M237.6 M73.4 M
Slightly volatile
Total Liabilities60 M57.1 M14.5 M
Slightly volatile
Total Current Assets20.8 M24.5 M14.2 M
Slightly volatile
Common Stock8.6 KK28.3 K
Slightly volatile
Accounts Payable2.1 M1.8 M1.3 M
Slightly volatile
Non Current Assets Total9.1 M8.6 M2.4 M
Slightly volatile
Other Assets0.860.9182.9 K
Slightly volatile
Common Stock Shares Outstanding7.6 M7.2 M10.7 M
Slightly volatile
Non Current Liabilities Total2.8 MM286.1 M
Pretty Stable
Property Plant And Equipment Net6.4 MM1.3 M
Slightly volatile
Property Plant And Equipment Gross8.2 M7.8 M1.6 M
Slightly volatile
Property Plant Equipment836.7 K796.9 K305.6 K
Slightly volatile
Short and Long Term Debt Total51.2 M48.7 M14.6 M
Slightly volatile
Long Term Debt256.5 K270 K1.2 M
Slightly volatile
Long Term Debt Total1.6 M1.7 M1.9 M
Slightly volatile
Short and Long Term Debt23.9 M44.2 M15.3 M
Slightly volatile
Capital Stock2.8 MM2.3 M
Slightly volatile
Short Term Debt24.5 M45.8 M15.6 M
Slightly volatile
Short Term Investments1.8 M2.7 M668 K
Slightly volatile
Current Deferred RevenueM3.7 M2.5 M
Slightly volatile
Net Receivables55.6 K61 K22.2 K
Slightly volatile
Inventory512 K539 KM
Pretty Stable
Preferred Stock Total EquityM2.3 M2.5 M
Slightly volatile
Intangible Assets1.4 M1.4 M1.6 B
Slightly volatile

PAVmed Series Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative32.5 M30.9 M11.2 M
Slightly volatile
Other Operating Expenses74.8 M71.2 M24.3 M
Slightly volatile
Research Development10.6 M14.3 M6.6 M
Slightly volatile
Total Operating Expenses33.1 M64.8 M20.8 M
Slightly volatile
Interest Income479.8 K505 K1.5 M
Slightly volatile
Reconciled Depreciation3.1 M2.9 M586.6 K
Slightly volatile
Cost Of Revenue6.7 M6.4 M1.2 M
Slightly volatile
Selling And Marketing Expenses13.4 M17.6 MM
Slightly volatile

PAVmed Series Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation5.8 M11.1 MM
Slightly volatile
Total Cash From Financing Activities27.3 M31.2 M18.8 M
Slightly volatile
End Period Cash Flow19 M19.6 M13.2 M
Slightly volatile
Begin Period Cash Flow41.7 M39.7 M13.2 M
Slightly volatile
Depreciation3.1 M2.9 M585 K
Slightly volatile
Dividends Paid10.7 B12.5 B6.1 B
Pretty Stable
Issuance Of Capital Stock29.4 M15.6 M15 M
Slightly volatile
Net Borrowings13.8 M15.6 M17 M
Slightly volatile
Cash And Cash Equivalents Changes8.8 M9.9 M10.8 M
Slightly volatile
Cash Flows Other Operating8.4 M9.4 M10.3 M
Slightly volatile
Change To Netincome1.6 M1.8 MM
Slightly volatile
Change To Liabilities1.1 M1.3 M1.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio11.5412.1509314
Slightly volatile
Dividend Yield3.0E-43.0E-43.0E-4
Slightly volatile
Days Sales Outstanding14.059.080315.8064
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue4.324.542828.0592
Slightly volatile
Capex To Depreciation0.07840.08253.6849
Slightly volatile
EV To Sales22.8124.013192
Slightly volatile
Inventory Turnover12.5111.91092.5793
Slightly volatile
Days Of Inventory On Hand29.1130.644110.1 K
Slightly volatile
Payables Turnover3.773.59460.5956
Slightly volatile
Sales General And Administrative To Revenue11.9912.621149.8038
Pretty Stable
Research And Ddevelopement To Revenue5.535.822237.0296
Slightly volatile
Capex To Revenue0.09380.09872.6356
Slightly volatile
Cash Per Share3.583.08523.6078
Slightly volatile
Days Payables Outstanding96.4610257.2 K
Slightly volatile
Income Quality0.510.81080.489
Slightly volatile
Intangibles To Total Assets0.03470.0430.0281
Slightly volatile
Current Ratio0.430.45227.1242
Slightly volatile
Receivables Turnover42.2140.19678.9722
Slightly volatile
Graham Number40.4838.553118.3371
Slightly volatile
Capex Per Share0.06570.03350.0583
Slightly volatile
Revenue Per Share0.360.33910.1282
Slightly volatile
Interest Debt Per Share4.126.19364.1094
Slightly volatile
Debt To Assets1.091.33461.0655
Slightly volatile
Operating Cycle37.7439.72442.4 K
Slightly volatile
Days Of Payables Outstanding96.4610257.2 K
Slightly volatile
Ebt Per Ebit1.411.15221.2831
Very volatile
Quick Ratio0.420.44227.0786
Slightly volatile
Net Income Per E B T1.020.80960.9657
Slightly volatile
Cash Ratio0.340.36257.0159
Slightly volatile
Days Of Inventory Outstanding29.1130.644110.1 K
Slightly volatile
Days Of Sales Outstanding14.059.080315.8064
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.811.00470.9943
Slightly volatile
Fixed Asset Turnover0.210.40530.298
Slightly volatile
Debt Ratio1.091.33461.0655
Slightly volatile
Price Sales Ratio11.5412.1509314
Slightly volatile
Asset Turnover0.07770.0740.0152
Slightly volatile

PAVmed Series Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap57.7 M29.8 M70.2 M
Slightly volatile
Enterprise Value62 M58.9 M71.4 M
Slightly volatile

PAVmed Fundamental Market Drivers

Cash And Short Term Investments19.6 M

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.7 MM
Total Revenue2.5 M1.5 M
Cost Of Revenue6.4 M6.7 M
Stock Based Compensation To Revenue 4.54  4.32 
Sales General And Administrative To Revenue 12.62  11.99 
Research And Ddevelopement To Revenue 5.82  5.53 
Capex To Revenue 0.10  0.09 
Revenue Per Share 0.34  0.36 
Ebit Per Revenue(28.06)(29.46)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.